P-076 The impact of heterogeneous disease distribution on MRD detection in patients with relapsed multiple myelomaLukas John, Niels Weinhold, Martin Grözinger et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
P-011 Hematopoietic reconstitution and infections after anti-BCMA CAR T-cell therapy in relapsed/ refractory multiple myeloma are associated with pre-CAR-T bridging therapiesJan Frenking, Marc S. Raab, Christian Michel et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0